首页> 外文期刊>Journal of Ophthalmic Inflammation and Infection >Probable Vogt–Koyanagi–Harada disease with initial unilateral ocular manifestation in a hepatitis C carrier
【24h】

Probable Vogt–Koyanagi–Harada disease with initial unilateral ocular manifestation in a hepatitis C carrier

机译:丙型肝炎携带者最初单侧眼部表现可能为Vogt–Koyanagi–Harada病

获取原文
       

摘要

Introduction Vogt–Koyanagi–Harada (VKH) disease is a systemic disorder with typical bilateral granulomatous panuveitis and variable degrees of systemic features, including meningismus, vitiligo, poliosis, and dysacusis. The exact pathogenesis remains unknown, and a theory of autoimmune response against certain antigenic component of melanocytes has been suggested [1]. Diagnosis is mainly based on clinical findings. Revised diagnostic criteria for VKH disease stressed the importance of the presence of bilateral uveitis [2]. Most patients do present with bilateral ocular involvement, where onset in the second eye might show 2 to 3 weeks of delay than the first eye. However, several cases of unilateral disease have also been reported after long-term follow-up [3]. Nowadays, the mainstay of treatment would be high dose systemic corticosteroid, although steroid-sparing agents should be considered in patients unable to tolerate steroid or in those who have developed steroid dependence [4]. Case report
机译:引言Vogt–Koyanagi–Harada(VKH)疾病是一种系统性疾病,典型的双侧肉芽肿性胰腺炎和不同程度的系统特征,包括脑膜炎,白癜风,小儿麻痹和吞咽困难。确切的发病机理仍是未知的,并且已经提出了针对黑素细胞的某些抗原成分的自身免疫反应的理论[1]。诊断主要基于临床发现。修订的VKH疾病诊断标准强调了双侧葡萄膜炎存在的重要性[2]。大多数患者的确有双眼受累,第二只眼的发病可能比第一只眼延迟了2至3周。然而,长期随访后也有几例单方面疾病的报道[3]。如今,治疗的主要手段是高剂量全身性皮质类固醇激素,尽管不能耐受类固醇激素的患者或已出现类固醇激素依赖性的患者应考虑使用类固醇激素抑制剂[4]。案例报告

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号